Article
Quantitative Assessment the Relationship between p21 rs1059234 Polymorphism and Cancer Risk.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2015
Huang Yong-Sheng, Fan Qian-Qian, Li Chuang, Nie Meng, Quan Hong-Yang, Wang Lin
Abstract excerpt
p21 is a cyclin-dependent kinase inhibitor, which can arrest cell proliferation and serve as a tumor suppressor. Though many studies were published to assess the relationship between p21 rs1059234 polymorphism and various cancer risks, there was no definite conclusion on this association. To derive a more precise quantitative assessment of the relationship, a large scale meta-analysis of 5,963 cases and 8,405...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
